Table 3

Total number of entries into arms in experiments examining the effects of CB ligands in the EPM test (experiments shown in Figure4)
(a) AM group Control NC IM NC-IM
Control group 63.2 ± 12.4 58.5 ± 11.9 60.8 ± 12.1 55.0 ± 11.7
AM 0.2 group 62.7 ± 12.6 58.9 ± 12.0 61.1 ± 12.3 55.5 ± 12.1
AM 1 group 62.4 ± 12.9 59.4 ± 12.2 61.5 ± 12.4 56.2 ± 12.4
AM 2.5 group 61.9 ± 13.1 59.9 ± 12.6 61.7 ± 12.7 57.5 ± 12.7
(b) CP group Control NC IM NC-IM
Control group 63.2 ± 12.4 58.5 ± 11.9 60.8 ± 12.1 55.0 ± 11.7
CP 0.5 group 62.6 ± 12.7 58.3 ± 12.0 60.6 ± 12.3 54.8 ± 12.1
CP 2 group 62.1 ± 12.8 58.0 ± 12.1 60.3 ± 12.4 54.7 ± 12.3
CP 5 group 61.5 ± 13.0 57.8 ± 12.2 60.0 ± 12.5 54.6 ± 12.5
(c) VD group Control NC IM NC-IM
Control group 63.2 ± 12.4 58.5 ± 11.9 60.8 ± 12.1 55.0 ± 11.7
VD 1 group 62.6 ± 12.6 58.8 ± 12.1 61.0 ± 12.4 54.9 ± 12.2
VD 5 group 62.3 ± 12.8 59.2 ± 12.2 61.3 ± 12.4 55.9 ± 12.4
VD 10 group 61.7 ± 13.0 59.5 ± 12.6 61.5 ± 12.7 56.9 ± 12.7

Hayase

Hayase BMC Neuroscience 2013 14:20   doi:10.1186/1471-2202-14-20

Open Data